Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
rzl-012 (6 trials)
Adiposis Dolorosa (Phase 2)
Lipedema (Phase 2)
Lipoma (Phase 2)
Obesity (Phase 2)
Overweight (Phase 2)
Weight Loss (Phase 2)
Trials (6 total)
Trial APIs (1 total)